|
|
||||||||
Ann Thorac Surg 2002;74:S1408-S1412
© 2002 The Society of Thoracic Surgeons
a The Department of Cardiovascular and Thoracic Surgery, University of Texas Southwestern Medical Center, Dallas, Texas, USA
* Address reprint requests to Dr Jessen, Department of Cardiovascular and Thoracic Surgery, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas TX 75390-8879, USA.
e-mail: michael.jessen{at}utsouthwestern.edu
Presented at the Eighth Annual Cardiothoracic Techniques and Technologies Meeting 2002, Miami Beach, FL, Jan 2326, 2002.
| Abstract |
|---|
|
|
|---|
METHODS: After a one-time PulseCO calibration, cardiac output was measured in 20 patients who had undergone coronary artery bypass grafting at 0, 2, 4, 6, and 8 hours after arrival in the intensive care unit using (1) thermodilution through a pulmonary artery catheter (Thermo); (2) lithium dilution (LiDCO); and (3) PulseCO. Concordance correlations were calculated between methods, and differences were compared by Wilcoxon paired rank test and Bland-Altman analysis.
RESULTS: Cardiac output ranged from 3.4 to 8.5 L/min. No significant differences were noted between measurements obtained by each technique at any time point. Concordance correlations and Bland-Altman analysis confirmed good agreement between PulseCO and Thermo determinations of cardiac output during the study interval.
CONCLUSIONS: PulseCO measurements remain reliable without recalibration for at least 8 hours after cardiac surgery and may offer a less-invasive approach for early postoperative cardiac output monitoring.
| Introduction |
|---|
|
|
|---|
Recently a less-invasive method has been introduced that may provide an attractive alternative for monitoring postoperative cardiac output. This method first applies the well-established indicator dilution technique to define cardiac output using lithium chloride as the indicator (LiDCO). The lithium dilution-derived cardiac output data are then used to calibrate a pressure waveform system (called PulseCO) that determines the nominal cardiac output through autocorrelation from a nonlinear transformation of the input analog arterial pressure [5]. PulseCO is thus capable of providing a beat-to-beat display of cardiac output.
After cardiac surgery, patients often experience fluctuations in temperature and vascular resistance, and may require changes in inotropic agents, vasopressors, or vasodilators. In addition, the arterial line is frequently used for blood sampling, which may result in overdamping of the transduced pressure signal. Because PulseCO relies completely on the arterial pressure waveform to calculate cardiac output, each of these factors may influence the reliability of PulseCO determinations. This study was designed to assess the accuracy of cardiac output measurements made by PulseCO compared with the thermodilution technique from a PA catheter in the immediate 8-hour period after coronary artery bypass grafting (CABG).
| Patients and methods |
|---|
|
|
|---|
After CABG surgery all patients were transported to the intensive care unit (ICU) for routine postoperative care. The study began upon arrival in the ICU. Cardiac output was measured within 10 minutes of arrival in the ICU by each of three techniques: thermodilution through a PA catheter (Oximetrix, Mountain View, CA), lithium dilution (LiDCO), and PulseCO (LiDCO, Ltd, Cambridge, UK). PulseCO provided an assessment of cardiac output based on a one-time calibration to the initial LiDCO measurement (Fig 1). No recalibration of PulseCO was made during the remainder of the study interval. Thermodilution cardiac output (Thermo) was calculated as the mean of three separate measurements obtained over 3 minutes by injection of 10 mL of room-temperature saline solution into the proximal port of the PA catheter at end-expiration. If an unstable base line message appeared, the resulting thermodilution value was discarded, and the process was repeated until a satisfactory measurement was obtained. LiDCO cardiac output was measured once at each time point, after a single injection of 1 to 2 mL of a 150 mmol/L LiCl solution (0.15 to 0.30 mmol LiCl, a physiologically irrelevant amount) through the side port of the introducer sheath in the right internal jugular vein. PulseCO provided continuous cardiac output data throughout the study, and the value displayed on the computer monitor at each time point was recorded. Other hemodynamic and basic physiologic data were recorded at the bedside during the study.
|
| Results |
|---|
|
|
|---|
Basic physiologic data are presented in Table 1. On average, body temperature (measured from a thermistor in the urinary bladder) increased by 1.8° ± 0.1°C (mean ± SEM) during the study period. Patients received an average of 1,041 ± 179 mL of blood products or intravenous fluids and averaged 1,565 ± 193 mL of urine output and 687 ± 178 mL of shed mediastinal blood during this interval. Cardiac output determinations for all patients were equivalent between methods at all time points. No differences were noted between measurements made with each method at any time point as assessed by the Wilcoxon paired rank test. Good correlation was observed between all methods based on concordance correlations (PulseCO versus Thermo, r = 0.86; LiDCO versus Thermo, r = 0.86; and PulseCO versus LiDCO, r = 0.99). Bland-Altman plots demonstrated good agreement between values obtained by PulseCO and Thermo at each time point (data not shown) and for all data collected (Fig 2). No tendency toward loss of agreement was noted at extreme values or at later time points compared with initial measurements.
|
|
| Comment |
|---|
|
|
|---|
The concept behind PulseCO is not new. Literature dating back to at least 1970 has suggested that cardiac output could be calculated and monitored based on the arterial blood pressure waveform [8, 9]. The relationship between blood volume and pressure within the arterial circulation can be thought of as compliance: pressure change per unit volume change. Determination of the change in blood volume in the arterial tree over the range of arterial distensibility would thus provide an estimate of the volume of blood flowing out of the arterial circuit during a period nearly equal to diastole. The cardiac cycle bears a nearly fixed relation to diastole, so one could theoretically determine stroke volume if the relationship remained constant at all pressures and volumes. Arterial compliance is not constant over the entire range of arterial pressure, but the relationship between pressure and volume remains similar among different subjects although different in scale. This fact enables the use of the arterial waveform and a defined relationship with pressure to describe the change in volume for every cardiac cycle. This change in volume can be thought of as the nominal stroke volume.
Cardiac output is equal to the product of heart rate and stroke volume. The PulseCO autocorrelation algorithm uses the cardiac cycle length (the elapsed time between systolic pressure waves) and the nominal stroke volume to calculate cardiac output. One must simply calibrate the nominal cardiac output derived by PulseCO to an independently measured cardiac output value. In this study, the independent cardiac output measurement used for calibration was provided by a lithium chloride indicator dilution technique (LiDCO).
Although thermodilution through a PA catheter is the most widely used measure of cardiac output clinically, this method cannot be considered the gold standard. In fact, after cardiac surgery, thermal variations in patients recently rewarmed using cardiopulmonary bypass have been cited as a potential source of error with this method [10]. Inaccuracies in the injectate volume or temperature can also cause error. Despite the limitations of thermodilution, if PulseCO is to be considered a valid alternative for cardiac output monitoring, it must at least demonstrate good agreement with this technique.
Two interesting findings emerged from this study. First, PulseCO provided estimates of cardiac output that were similar to those derived from thermodilution techniques. Of the 100 data points plotted in Figure 2, only four deviated by more than 2 standard deviations from the mean difference between techniques. Second, over the 8-hour study period, no significant differences between these two techniques emerged. This similarity persisted despite changes in systemic vascular resistance; the use of vasoactive drugs; volume infusion and volume loss; and the use of the arterial line for blood sampling. LiDCO measurements were made at all time points to assess the need for frequent recalibration of the PulseCO system. Based on these data, recalibration appears to be unnecessary in the first 8 hours after cardiac surgery.
PulseCO measurements correlated well with both the thermodilution and LiDCO determinations of cardiac output. Our data therefore attest to the accuracy of this method under the conditions studied. However, PulseCO may have advantages over PA catheter-derived thermodilution measurements. Because PulseCO provides a beat-to-beat readout, abrupt changes in cardiac output resulting from tamponade, blood loss, or changes in vascular tone may be detected more quickly. Additionally, no catheterization of the PA is needed, avoiding potential complications. In fact, a central line can be avoided completely with the PulseCO method, as the LiDCO calibration can be performed by lithium injection from a peripheral vein.
This study was limited by use of a low-risk patient population and a relatively small sample size. Low-risk patients were selected to gain familiarity with the technique in a controlled environment. However, many authors are of the opinion that low-risk patients do not require any perioperative assessment of cardiac output [2, 3]. Although our results demonstrate good agreement between PulseCO data and thermodilution measurements, further studies will be required to assess these techniques in higher-risk patients and in the setting of hemodynamic instability or arrhythmias.
In conclusion, these data suggest that PulseCO measurements of cardiac output are reliable in patients for at least 8 hours after cardiac operations, despite the potential inherent fluctuations in the arterial pressure waveform caused by temperature changes; use of vasopressors, inotropic agents, or vasodilators; or use of the arterial line for blood sampling. Additionally, recalibration of PulseCO appears to be unnecessary for at least 8 hours after initial LiDCO calibration. This technique appears to offer a safe, reliable, and less-invasive alternative to the traditional PA catheter for cardiac output monitoring in the immediate postoperative period after cardiac surgery.
| Acknowledgments |
|---|
|
|
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
J. Vuyk, B. J. Lichtenbelt, E. Olofsen, J. W. van Kleef, and A. Dahan Mixed-Effects Modeling of the Influence of Midazolam on Propofol Pharmacokinetics Anesth. Analg., May 1, 2009; 108(5): 1522 - 1530. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Compton and J.-H. Schafer Noninvasive Cardiac Output Determination: Broadening the Applicability of Hemodynamic Monitoring Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2009; 13(1): 44 - 55. [Abstract] [PDF] |
||||
![]() |
H. M. C. Kemps, E. J. M. Thijssen, G. Schep, B. T. H. M. Sleutjes, W. R. De Vries, A. R. Hoogeveen, P. F. F. Wijn, and P. A. F. M. Doevendans Evaluation of two methods for continuous cardiac output assessment during exercise in chronic heart failure patients J Appl Physiol, December 1, 2008; 105(6): 1822 - 1829. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Matthieu, N.-G. Karine, C. Vincent, V. Alain, C. J. Francois, R. Philippe, and S. Francois Cardiac Output Measurement in Patients Undergoing Liver Transplantation: Pulmonary Artery Catheter Versus Uncalibrated Arterial Pressure Waveform Analysis Anesth. Analg., May 1, 2008; 106(5): 1480 - 1486. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Giomarelli, B. Biagioli, and S. Scolletta Cardiac output monitoring by pressure recording analytical method in cardiac surgery Eur. J. Cardiothorac. Surg., September 1, 2004; 26(3): 515 - 520. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |